Gene Therapy Supply Chain & CDMO Market, By Product Type (Gene Therapy, Gene-Modified Cell Therapy, and Cell Therapy), By Service Type, By Technology, By Scale, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4038
|
Published Date
June 2025
|
Pages
400
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Gene Therapy Supply Chain & CDMO Market size was valued at US$ XX Million in 2024, expanding at a CAGR of 15.9% from 2025 to 2032.
The Gene Therapy Supply Chain & CDMO market encompasses the specialized production, development, and distribution services crucial for delivering gene therapies from the laboratory to patients. The increasing number of gene therapy approvals—targeting rare genetic disorders and cancers—is driving demand for advanced viral vector manufacturing and stringent cold chain logistics to maintain product integrity. For example, by 2024, the U.S. FDA has authorized over 30 gene therapies, while thousands of ongoing clinical trials worldwide require scalable and reliable manufacturing support. Key challenges include the high production costs, complex regulatory requirements, and the necessity for ultra-cold storage solutions. Nonetheless, the market presents significant growth opportunities fueled by innovations in automated manufacturing, the expansion of modular production facilities, and strategic collaborations between biotech companies and Contract Development and Manufacturing Organizations (CDMOs), all aimed at optimizing supply chains and addressing the increasing global demand for personalized gene therapies.
Gene Therapy Supply Chain & CDMO Market- Market Dynamics
Growing Gene Therapy Approvals and Manufacturing Challenges Drive Innovation in CDMO and Supply Chain
The rapid growth in gene therapy approvals, coupled with the increasing complexity of manufacturing processes, is driving significant innovation in the Gene Therapy Supply Chain & CDMO market. In 2024, the U.S. FDA approved several breakthrough therapies, including Casgevy™ (exagamglogene autotemcel) for sickle cell disease and Lyfgenia™ (lovotibeglogene autotemcel) for beta-thalassemia. Other notable approvals, such as Beqvez™ (fidanacogene elaparvovec) for hemophilia B and Tecelra™ (afamitresgene autoleucel) for synovial sarcoma, underscore the expanding range of gene therapy applications. These advancements require highly specialized manufacturing capabilities, including viral vector production, cell processing, and rigorous cold chain logistics to ensure product integrity.
Despite challenges like high production costs, stringent regulatory compliance, and the need for scalable infrastructure, the market presents promising opportunities. Globally, governments are actively supporting the sector; for instance, the European Commission has allocated over €2 billion through its Horizon Europe program to accelerate gene therapy research and manufacturing innovations. Additionally, countries such as Japan and China are investing heavily in expanding gene therapy infrastructure to meet rising patient demand. Innovations such as modular manufacturing platforms, strategic collaborations between biotech companies and CDMOs, and advancements in automation and digital tracking are enhancing efficiency and scalability across gene therapy production and distribution.
Gene Therapy Supply Chain & CDMO Market- Segmentation Analysis:
The Global Gene Therapy Supply Chain & CDMO Market is segmented on the basis of Product Type, Service Type, Technology, Scale, End User, and Region.
The market for advanced therapies is segmented into three main product types: Gene Therapy, Gene-Modified Cell Therapy, and Cell Therapy. Gene therapy encompasses both ex vivo and in vivo approaches aimed at correcting genetic disorders by directly modifying patient DNA. Gene-modified cell therapies, including CAR T-cell and CAR-NK therapies, represent a breakthrough in targeted cancer treatment by engineering immune cells to recognize and attack malignant cells. Cell therapy primarily focuses on regenerative medicine, utilizing stem cells or other cell types to repair or replace damaged tissues. Collectively, these therapies are transforming personalized medicine across a wide range of therapeutic areas such as oncology, rare genetic diseases, and degenerative conditions. According to the U.S. National Institutes of Health (NIH), federal funding for gene and cell therapy research has grown by over 40% between 2018 and 2024, reflecting increased government commitment to accelerating innovation in this transformative field.
From a service perspective, the market is divided into six critical categories: Vector Manufacturing (including Adeno-Associated Virus (AAV), Lentivirus, and Retrovirus vectors), Cell Processing, Formulation & Fill-Finish, Analytical Testing & Quality Control, Regulatory Support, and Logistics & Cold Chain Management. Vector manufacturing, particularly with AAV and lentivirus vectors, is fundamental to effective gene delivery and therapy success. Cell processing prepares living cells for therapeutic use, while formulation and fill-finish steps ensure product stability and safety. Analytical testing and quality control are vital for maintaining rigorous standards, regulatory support streamlines approval pathways, and logistics with specialized cold chain management safeguard the integrity of therapies during transport and storage. The U.S. Food and Drug Administration (FDA) reported in 2023 that over 60% of new gene and cell therapy products approved in the last two years benefited from enhanced regulatory support programs, highlighting government efforts to facilitate timely patient access to these cutting-edge treatments.
Gene Therapy Supply Chain & CDMO Market- Geographical Insights
The Gene Therapy Supply Chain & CDMO market exhibits significant regional variation, with North America leading the sector due to its advanced biopharmaceutical infrastructure, supportive regulatory environment, and early adoption of gene therapies. The U.S. plays a central role, hosting numerous CDMOs and biotech companies specializing in viral vector manufacturing and cell processing. Europe follows closely, driven by increased government funding and strong collaboration among research institutions, particularly in Germany, France, and the UK. For example, the European Commission has committed over €2 billion through its Horizon Europe program to advance gene therapy research and manufacturing capabilities. The Asia-Pacific region is rapidly emerging as a key market, supported by growing healthcare investments, a rise in clinical trials, and expanding biotech hubs in China, Japan, and South Korea. Governments in this region are also launching initiatives to boost gene therapy innovation, such as China’s National Science and Technology Major Project on biotechnology. However, challenges such as cold chain logistics and regulatory complexities vary across regions, affecting supply chain efficiency. Furthermore, regions with well-established hospital networks and treatment centers, like North America and Europe, are better equipped for the swift deployment of gene therapies. This geographical diversity underscores opportunities for localized manufacturing solutions and strategic partnerships tailored to meet the distinct demands of global markets.
Gene Therapy Supply Chain & CDMO Market- Competitive Landscape:
The competitive landscape of the Gene Therapy Supply Chain & CDMO market features a diverse mix of specialized contract development and manufacturing organizations, major biopharmaceutical companies, and innovative biotech firms focused on cutting-edge gene and cell therapy solutions. Leading players are heavily investing in expanding viral vector manufacturing capacity, advanced cell processing technologies, and scalable fill-finish operations to keep pace with rising demand. Strategic collaborations between CDMOs and biopharma companies are increasingly common, aiming to accelerate development timelines and optimize supply chain efficiency. Additionally, companies are enhancing cold chain logistics and quality control protocols to maintain product stability and meet stringent regulatory requirements. Regional competitors in North America, Europe, and Asia-Pacific leverage local expertise, regulatory familiarity, and proximity to clinical trial hubs to strengthen their market positions. The fast-evolving market fosters continuous innovation in manufacturing technologies, automation, and digital tracking systems, which have become crucial differentiators in this competitive space.
Recent Developments:
- In November 2024, iotaSciences launched the Single-Cell Cloning Platform XT, featuring AI-powered Single-Cell Automated Identification (SCAI) technology. This next-generation system automates single-cell isolation, culture, and monoclonality verification, enhancing R&D workflows in gene therapy manufacturing.
- In June 2024, Cryoport and Minaris Regenerative Medicine entered a strategic partnership to offer fully integrated logistics and manufacturing services for cell and gene therapies, streamlining supply chains and supporting the global advancement of regenerative medicine products.
- In May 2025, 3PBIOVIAN introduced the AAVion Platform, a comprehensive solution for adeno-associated virus (AAV) manufacturing, covering vector design through aseptic fill and finish. Their standalone Plasmid Platform provides GMP-grade plasmid DNA from research to commercial scales worldwide.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AGC Biologics
- AskBio (a part of Bayer)
- Brammer Bio (a part of Thermo Fisher)
- Catalent, Inc.
- Charles River Laboratories
- Cobra Biologics
- Fujifilm Diosynth Biotechnologies
- Lonza Group
- Novasep
- Oxford Biomedica
- Oxford Biomedica
- Parexel International
- Samsung Biologics
- Thermo Fisher Scientific
- VGXI, Inc.
- WuXi AppTec
- Others
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Gene Therapy
- Ex-vivo
- In-vivo
- Gene-Modified Cell Therapy
- CAR T-cell Therapies
- CAR-NK Cell Therapy
- TCR-T Cell Therapy
- Other
- Cell Therapy
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032
- Vector Manufacturing (AAV, Lentivirus, Retrovirus)
- Cell Processing
- Formulation & Fill-Finish
- Analytical Testing & Quality Control
- Regulatory Support
- Logistics & Cold Chain Management
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Viral Vector Technology
- Non-Viral Vector Technology
- Cell & Gene Editing Technologies (CRISPR, TALEN)
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY SCALE- MARKET ANALYSIS, 2019 - 2032
- Preclinical & Clinical-Stage Manufacturing
- Commercial-Scale Manufacturing
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Biopharmaceutical Companies
- Research Institutes
- Hospitals & Treatment Centers
GLOBAL GENE THERAPY SUPPLY CHAIN & CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Gene Therapy Supply Chain & CDMO Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Gene Therapy Supply Chain & CDMO Market Snippet by Product Type
2.1.2. Gene Therapy Supply Chain & CDMO Market Snippet by Service Type
2.1.3. Gene Therapy Supply Chain & CDMO Market Snippet by Technology
2.1.4. Gene Therapy Supply Chain & CDMO Market Snippet by Scale
2.1.5. Gene Therapy Supply Chain & CDMO Market Snippet by End User
2.1.6. Gene Therapy Supply Chain & CDMO Market Snippet by Country
2.1.7. Gene Therapy Supply Chain & CDMO Market Snippet by Region
2.2. Competitive Insights
3. Gene Therapy Supply Chain & CDMO Key Market Trends
3.1. Gene Therapy Supply Chain & CDMO Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Gene Therapy Supply Chain & CDMO Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Gene Therapy Supply Chain & CDMO Market Opportunities
3.4. Gene Therapy Supply Chain & CDMO Market Future Trends
4. Gene Therapy Supply Chain & CDMO Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Gene Therapy Supply Chain & CDMO Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Gene Therapy Supply Chain & CDMO Market Landscape
6.1. Gene Therapy Supply Chain & CDMO Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Gene Therapy Supply Chain & CDMO Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Gene Therapy
7.1.2.1. Ex-vivo
7.1.2.2. In-vivo
7.1.3. Gene-Modified Cell Therapy
7.1.3.1. CAR T-cell Therapies
7.1.3.2. CAR-NK Cell Therapy
7.1.3.3. TCR-T Cell Therapy
7.1.3.4. Other
7.1.4. Cell Therapy
8. Gene Therapy Supply Chain & CDMO Market – By Service Type
8.1. Overview
8.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
8.1.2. Vector Manufacturing (AAV, Lentivirus, Retrovirus)
8.1.3. Cell Processing
8.1.4. Formulation & Fill-Finish
8.1.5. Analytical Testing & Quality Control
8.1.6. Regulatory Support
8.1.7. Logistics & Cold Chain Management
9. Gene Therapy Supply Chain & CDMO Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
9.1.2. Viral Vector Technology
9.1.3. Non-Viral Vector Technology
9.1.4. Cell & Gene Editing Technologies (CRISPR, TALEN)
10. Gene Therapy Supply Chain & CDMO Market – By Scale
10.1. Overview
10.1.1. Segment Share Analysis, By Scale, 2024 & 2032 (%)
10.1.2. Preclinical & Clinical-Stage Manufacturing
10.1.3. Commercial-Scale Manufacturing
11. Gene Therapy Supply Chain & CDMO Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Biopharmaceutical Companies
11.1.3. Research Institutes
11.1.4. Hospitals & Treatment Centers
12. Gene Therapy Supply Chain & CDMO Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Gene Therapy Supply Chain & CDMO Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Gene Therapy Supply Chain & CDMO Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Gene Therapy Supply Chain & CDMO Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Gene Therapy Supply Chain & CDMO Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Gene Therapy Supply Chain & CDMO Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Gene Therapy Supply Chain & CDMO Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. AGC Biologics
13.2.2. AskBio (a part of Bayer)
13.2.3. Brammer Bio (a part of Thermo Fisher)
13.2.4. Catalent, Inc.
13.2.5. Charles River Laboratories
13.2.6. Cobra Biologics
13.2.7. Fujifilm Diosynth Biotechnologies
13.2.8. Lonza Group
13.2.9. Novasep
13.2.10. Oxford Biomedica
13.2.11. Oxford Biomedica
13.2.12. Parexel International
13.2.13. Samsung Biologics
13.2.14. Thermo Fisher Scientific
13.2.15. VGXI, Inc.
13.2.16. WuXi AppTec
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
